Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-10

FDA Approved: CHLORZOXAZONE — Original Application (Lifsa Drugs LLC)

View source ↗

Summary

The FDA approved Lifsa Drugs LLC's chlorzoxazone under ANDA214702 as an original application for a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorzoxazone (Chlorzoxazone)

Snippet

ORIG AP for CHLORZOXAZONE (CHLORZOXAZONE)